The RCPI national clinical lead for the stroke programme says we should have a comprehensive vaccine schedule to protect ...

Correspondence to Dr Christopher Thomas Hood, Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan 48105, USA; hoodc{at}med.umich.edu Background/Aim To review the long-term ...

The recombinant herpes zoster vaccine is effective in older adults regardless of a patient’s immunocompromised status, based on data from more than 3 million adults aged 65 years or older. The ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Orbital apex syndrome is a rare neuro-ophthalmic manifestation of herpes zoster virus infection. We report one such case with favourable outcome in an immunocompetent patient. A 60-year-old woman ...

Seventy-one patients presenting with acute herpes zoster ophthalmicus were followed up for six months for a prospective analysis of the natural history of the disease. Acute and chronic ocular ...

Two doses of the recombinant herpes zoster (HZ; shingles) vaccine (RZV) are effective even for people who previously received ...

The researchers found that vaccine effectiveness was 56.1% against any herpes zoster (HZ) outcome, with similar vaccine effectiveness for immunocompetent and immunocompromised individuals.

A target trial emulation was conducted to assess the effectiveness of recombinant zoster vaccine (RZV) accounting for prior ...

Acyclovir (as sodium) 500mg/vial; lyophilized pwd for IV infusion after reconstitution and dilution; contains sodium 49mg/vial. Give by IV infusion over 1 hour. Mucocutaneous herpes simplex ...